Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs for Knee Osteoarthritis
NCT03358654Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Jan 2018
- Primary completion
- Jun 2020
- Modality
- Stem Cell Therapies
01
Overview
Open-label, single-arm trial of Human umbilical cord mesenchymal stem cells in knee osteoarthritis (OA), sponsored by Peking University People's Hospital. Primary endpoint: Unexplained local and systemic symptoms or death at 6 months. Status: unknown.
02
Drugs
Human umbilical cord mesenchymal stem cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03358654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03358654.